Search - tctmd.com

Displaying 141 - 160 of 924

Sort: Relevancy | Date

Presentation TCT 2023

TCT 54: Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Daijiro Tomii

October 26, 2023

Presentation TCT 2023

Structural Keynote Lecture: Essentials of Lifetime Management of Aortic Disease in 2023

Presenter: Eberhard Grube

October 26, 2023

Presentation TCT 2023

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

Who Are the TTVR Patients We Are Treating and What Are the Challenges?

Presenter: Marta Sitges

October 26, 2023

Presentation TCT 2023

TCT 68: Cardiac Implantable Electronic Device Lead-Related Tricuspid Regurgitation in Patients Presenting for Transcatheter Tricuspid Valve Interventions

Presenter: Baban Kumar

October 26, 2023

Presentation TCT 2023

TCT 775: A Machine Learning Based Model Predicts Death in Patients with Severe Asymptomatic Aortic Stenosis

Presenter: APURVA BHARUCHA

October 26, 2023

Presentation TCT 2023

TCT 760: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation- A Systematic Review and Meta Analysis

Presenter: Irfan Ullah

October 26, 2023

Presentation TCT 2023

TCT 753: Development of a Machine Learning Based Futility Risk Model to Predict One Year Mortality in Transcatheter Aortic Valve Replacement

Presenter: APURVA BHARUCHA

October 26, 2023

Presentation TCT 2023

TCT 597: Transcatheter Tricuspid Valve Replacement: From Preclinical to Early First-in-Human Experiences with the MonarQ Device

Presenter: Arshad Quadri

October 26, 2023

$TCT 752: Combined valvular and subvalvular intervention with Innovalve TMVR facilitates reverse remodeling and improves left ventricular ejection fraction in patients with severe chronic mitral regurgitation$

Presentation TCT 2023

TCT 752: Combined valvular and subvalvular intervention with Innovalve TMVR facilitates reverse remodeling and improves left ventricular ejection fraction in patients with severe chronic mitral regurgitation (TWIST-EFS and FIH studies)

Presenter: Chet Rihal

October 26, 2023

Presentation TCT 2023

TCT 777: Comparison of U.S. Hospital Costs between Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement in 2019-2022 Q3 Claims Data

Presenter: Jennifer Williams

October 26, 2023

Presentation TCT 2023

Can We Do Better? Next Generation LAAO Devices

Presenter: Saibal Kar

October 26, 2023

Presentation TCT 2023

TCT 906: Leaflet Thrombosis in a patient with Severe, Bicuspid Aortic Valve Stenosis and Severely Depressed LVEF: Acute Leaflet Thrombosis Less than 24 Hours After Evolut R Implantation

Presenter: Fabio Enrique Posas

October 26, 2023

Presentation TCT 2023

TCT 905: Acute Valve Leaflet Thrombosis After Transcatheter Aortic Valve Replacement

Presenter: Dhruv Sarma

October 26, 2023

Presentation TCT 2023

AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?

Presenter: Edip Gurol

October 26, 2023

Presentation TCT 2023

Case: When Alternative Therapeutic Approaches Are Needed

Presenter: Fabio Brito Jr.

October 26, 2023

Presentation TCT 2023

TCT 458: Outcomes and Trends of Transcatheter Edge to Edge Repair in the Mitral Valve Prolapse

Presenter: Aneeza Jamshed

October 26, 2023

Presentation TCT 2023

TCT 748: Innovalve TMVR clinical data from TWIST-EFS and FIH studies

Presenter: Chet Rihal

October 26, 2023

Presentation TCT 2023

TCT 459: Cardiac power output or stroke volume index to predict outcome in transcatheter aortic valve implantation

Presenter: Norman Mangner

October 26, 2023

Presentation TCT 2023

TCT 636: Evaluating The Performance of XGBoost Artificial Intelligence Modelling for Predicting Early Hospital Discharge Following Transcatheter Aortic Valve Replacement

Presenter: Chapman Wei

October 26, 2023

Advertisement

TCT 54: Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement

Structural Keynote Lecture: Essentials of Lifetime Management of Aortic Disease in 2023

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

Who Are the TTVR Patients We Are Treating and What Are the Challenges?

TCT 68: Cardiac Implantable Electronic Device Lead-Related Tricuspid Regurgitation in Patients Presenting for Transcatheter Tricuspid Valve Interventions

TCT 775: A Machine Learning Based Model Predicts Death in Patients with Severe Asymptomatic Aortic Stenosis

TCT 760: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation- A Systematic Review and Meta Analysis

TCT 753: Development of a Machine Learning Based Futility Risk Model to Predict One Year Mortality in Transcatheter Aortic Valve Replacement

TCT 597: Transcatheter Tricuspid Valve Replacement: From Preclinical to Early First-in-Human Experiences with the MonarQ Device

TCT 752: Combined valvular and subvalvular intervention with Innovalve TMVR facilitates reverse remodeling and improves left ventricular ejection fraction in patients with severe chronic mitral regurgitation (TWIST-EFS and FIH studies)

TCT 777: Comparison of U.S. Hospital Costs between Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement in 2019-2022 Q3 Claims Data

Can We Do Better? Next Generation LAAO Devices

TCT 906: Leaflet Thrombosis in a patient with Severe, Bicuspid Aortic Valve Stenosis and Severely Depressed LVEF: Acute Leaflet Thrombosis Less than 24 Hours After Evolut R Implantation

TCT 905: Acute Valve Leaflet Thrombosis After Transcatheter Aortic Valve Replacement

AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?

Case: When Alternative Therapeutic Approaches Are Needed

TCT 458: Outcomes and Trends of Transcatheter Edge to Edge Repair in the Mitral Valve Prolapse

TCT 748: Innovalve TMVR clinical data from TWIST-EFS and FIH studies

TCT 459: Cardiac power output or stroke volume index to predict outcome in transcatheter aortic valve implantation

TCT 636: Evaluating The Performance of XGBoost Artificial Intelligence Modelling for Predicting Early Hospital Discharge Following Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content